$CLVS May 29 ASCO meeting, CLVS has several presentations... FDA approval to use already available and used OC drug for PC, I thought, was a great fucking deal. The stock tanked 30% instead... well, what do I know, except that this has a potential for being a billion dollar drug company. JMO
  • 3